56 results
424B3
NNMX
NANOMIX Corp
12 Jul 22
Prospectus supplement
8:44pm
devices.
The regulatory requirements that apply to our approved products classified as medical devices include:
product listing and establishment … accrued interest to the former President of the Company. Dr. Platt’s notes and accrued interest remain outstanding and are classified as current
424B3
qva9l9 e8gpecq1d
17 May 22
Prospectus supplement
6:11am
8-K
EX-10.1
a2o3t7id3p
1 Mar 22
Entry into a Material Definitive Agreement
8:58am
8-K/A
EX-99.6
gpij 4g2jrv5jqoza
5 Nov 21
Other Events
4:47pm
SC 14F1
noig9zqc3naevbu
23 Jul 21
Statement regarding change in majority of directors
5:00pm
8-K
EX-10.1
nexkjikz62n 9q
29 Jun 21
Boston Therapeutics Announces $8.4 Million Convertible Placement
9:06am
8-K
EX-10.3
hyafj9pv6o1c r8p
29 Jun 21
Boston Therapeutics Announces $8.4 Million Convertible Placement
9:06am
8-K
EX-2.1
iio2tvkb
2 Feb 21
Entry into a Material Definitive Agreement
5:00pm